Introducing Innovative Cellular Therapies into the Clinic: A 2-Year Retrospective Experience of a Chimeric Antigen Receptor T-Cell Programme at a Single Centre in Switzerland. Swiss Med Wkly 2022, 152 (2526), w30186. https://doi.org/10.4414/SMW.2022.w30186.